The purpose of this two-patient feasibility trial is to determine whether normal and/or abnormal hematopoietic progenitor cell populations can be detected in leukapheresis samples obtained from PNH patients and whether such cell populations are detectable using a steady-state leukapheresis, i.e. collection of cells without using techniques designed to enhance release of hematopoietic progenitor cells from bone marrow into peripheral blood.
Showing the most recent 10 out of 753 publications